---
title: "Mirxes Faces Ongoing Trading Suspension as Auditors Probe Prepayments and Large Cash Outflows"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285841209.md"
description: "Mirxes Holding Company Limited (HK:2629) is facing an ongoing trading suspension due to unresolved auditor concerns regarding significant prepayments and large cash outflows. KPMG has raised questions about the selection process for service providers and the reasonableness of contract terms. The company reported material cash outflows totaling approximately US$57 million and RMB10 million for investments and advisory fees. These issues are under review by an independent investigation committee, affecting Mirxes' governance and trading resumption conditions. The company focuses on expanding its laboratory testing and manufacturing capabilities in the life sciences sector."
datetime: "2026-05-10T12:07:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285841209.md)
  - [en](https://longbridge.com/en/news/285841209.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285841209.md)
---

# Mirxes Faces Ongoing Trading Suspension as Auditors Probe Prepayments and Large Cash Outflows

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The latest announcement is out from Mirxes Holding Company Limited ( (HK:2629) ).

Mirxes Holding Company Limited has issued a supplemental announcement on resumption guidance and continued suspension of trading, detailing auditor KPMG’s unresolved concerns over significant prepayments to certain service providers and vendors. The auditors have questioned the counterparties’ background, selection process, compliance with procurement policies, progress of related projects, and the commercial reasonableness of contract amounts and upfront payment terms.

The company also disclosed material cash outflows after December 31, 2025, totaling about US$57 million and RMB10 million, mainly for interest-bearing deposits and investments in new sequencing and production equipment, intellectual property, and advisory fees. These substantial outflows, identified as subsequent events by KPMG, are expected to be included in an independent investigation committee’s ongoing review, prolonging scrutiny over Mirxes’ governance, capital deployment, and the conditions for resumption of trading in its shares.

**More about Mirxes Holding Company Limited**

Mirxes Holding Company Limited is a Cayman Islands–incorporated company listed on the Hong Kong Stock Exchange, operating through a group structure that includes various subsidiaries. The group focuses on expanding its laboratory testing capacity, manufacturing facilities, and proprietary intellectual property portfolio, indicating a presence in technology- and equipment-intensive life sciences or diagnostics-related businesses.

**Average Trading Volume:** 7,798,402

**Technical Sentiment Signal:** Strong Sell

**Current Market Cap:** HK$3.54B

### Related Stocks

- [02629.HK](https://longbridge.com/en/quote/02629.HK.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [513200.CN](https://longbridge.com/en/quote/513200.CN.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [512170.CN](https://longbridge.com/en/quote/512170.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)

## Related News & Research

- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Manulife Singapore to offer multi-cancer blood test starting May](https://longbridge.com/en/news/286710691.md)
- [Basecare Wins NMPA Class III Approval for Gems Embryo Culture Medium](https://longbridge.com/en/news/286258287.md)
- [HBM Holdings Says Director Probed by CSRC, Sees No Impact on Operations](https://longbridge.com/en/news/286197909.md)
- [Broncus shareholders back all AGM resolutions, update articles of association](https://longbridge.com/en/news/286439966.md)